{"count": 21, "results": [{"_id": "36017310", "pmid": 36017310, "pmcid": "PMC9396276", "title": "Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort", "journal": "Front Endocrinol (Lausanne)", "authors": ["Hafidh K", "Malek R", "Al-Rubeaan K", "Kok A", "Bayram F", "Echtay A", "Rajadhyaksha V", "Hadaoui A"], "date": "2022-08-09T00:00:00Z", "doi": "10.3389/fendo.2022.940309", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "940309", "score": 50277.42, "text_hl": "...The data on @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@vascular complications@@@ included:", "citations": {"NLM": "Hafidh K, Malek R, Al-Rubeaan K, Kok A, Bayram F, Echtay A, Rajadhyaksha V, Hadaoui A. Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort Front Endocrinol (Lausanne). 2022;13():940309. PMID: 36017310", "BibTeX": "@article{36017310, title={Prevalence and risk factors of vascular complications in type 2 diabetes mellitus: Results from discover Middle East and Africa cohort}, author={Hafidh K and Malek R and Al-Rubeaan K and Kok A and Bayram F and Echtay A and Rajadhyaksha V and Hadaoui A}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={940309}}"}}, {"_id": "37901890", "pmid": 37901890, "pmcid": "PMC10604500", "title": "Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions", "journal": "Clin Med Insights Endocrinol Diabetes", "authors": ["Khadilkar A", "Oza C", "Mondkar SA"], "date": "2023-10-26T00:00:00Z", "doi": "10.1177/11795514231206730", "meta_date_publication": "2023", "meta_volume": "16", "meta_issue": "", "meta_pages": "11795514231206730", "score": 50258.707, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ adjunct therapy in @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@T1DM@@@ has been shown to improve @GENE_INS @GENE_3630 @@@insulin@@@ sensitivity, glycemic control, @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ profile, body composition, vascular smooth muscle function, thereby reducing the risk of @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@vascular complications@@@, as well as reversal of early @DISEASE_Cerebrovascular_Disorders @DISEASE_MESH:D002561 @@@vascular dysfunction@@@. ", "citations": {"NLM": "Khadilkar A, Oza C, Mondkar SA. Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions Clin Med Insights Endocrinol Diabetes. 2023;16():11795514231206730. PMID: 37901890", "BibTeX": "@article{37901890, title={Insulin Resistance in Adolescents and Youth With Type 1 Diabetes: A Review of Problems and Solutions}, author={Khadilkar A and Oza C and Mondkar SA}, journal={Clin Med Insights Endocrinol Diabetes}, volume={16}, pages={11795514231206730}}"}}, {"_id": "35802672", "pmid": 35802672, "pmcid": "PMC9269956", "title": "Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium", "journal": "PLoS One", "authors": ["Li Y", "Gappy S", "Liu X", "Sassalos T", "Zhou T", "Hsu A", "Zhang A", "Edwards PA", "Gao H", "Qiao X"], "date": "2022-07-08T00:00:00Z", "doi": "10.1371/journal.pone.0268451", "meta_date_publication": "2022", "meta_volume": "17", "meta_issue": "7", "meta_pages": "e0268451", "score": 50257.12, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@'s possible anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ function in @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@diabetic vasculopathy@@@, irrespective of @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ control, has garnered considerable study interest. ", "citations": {"NLM": "Li Y, Gappy S, Liu X, Sassalos T, Zhou T, Hsu A, Zhang A, Edwards PA, Gao H, Qiao X. Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium PLoS One. 2022;17(7):e0268451. PMID: 35802672", "BibTeX": "@article{35802672, title={Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium}, author={Li Y and Gappy S and Liu X and Sassalos T and Zhou T and Hsu A and Zhang A and Edwards PA and Gao H and Qiao X}, journal={PLoS One}, volume={17}, number={7}, pages={e0268451}}"}}, {"_id": "35351535", "pmid": 35351535, "title": "Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial.", "journal": "Diabetes Res Clin Pract", "authors": ["Elbarbary NS", "Ismail EAR", "Ghallab MA"], "date": "2022-04-01T00:00:00Z", "doi": "10.1016/j.diabres.2022.109857", "meta_date_publication": "2022 Apr", "meta_volume": "186", "meta_issue": "", "meta_pages": "109857", "score": 50256.58, "text_hl": "Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as an add-on therapy on @GENE_NRG4 @GENE_145957 @@@neuregulin-4@@@ levels and @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@vascular-related complications@@@ in adolescents with @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@type 1 diabetes@@@: A randomized controlled trial.", "citations": {"NLM": "Elbarbary NS, Ismail EAR, Ghallab MA. Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial. Diabetes Res Clin Pract. 2022 Apr;186():109857. PMID: 35351535", "BibTeX": "@article{35351535, title={Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial.}, author={Elbarbary NS and Ismail EAR and Ghallab MA}, journal={Diabetes Res Clin Pract}, volume={186}, pages={109857}}"}}, {"_id": "40282226", "pmid": 40282226, "title": "Mitigating Diabetic Cardiomyopathy: The Synergistic Potential of Sea Buckthorn and Metformin Explored via Bioinformatics and Chemoinformatics.", "journal": "Biology (Basel)", "authors": ["Safavi K", "Abedpoor N", "Hajibabaie F", "Kaviani E"], "date": "2025-03-31T00:00:00Z", "doi": "10.3390/biology14040361", "meta_date_publication": "2025 Mar 31", "meta_volume": "14", "meta_issue": "4", "meta_pages": "", "score": 50247.895, "text_hl": "Mitigating @DISEASE_Diabetic_Cardiomyopathies @DISEASE_MESH:D058065 @@@Diabetic Cardiomyopathy@@@: The Synergistic Potential of Sea Buckthorn and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Explored via Bioinformatics and Chemoinformatics.", "citations": {"NLM": "Safavi K, Abedpoor N, Hajibabaie F, Kaviani E. Mitigating Diabetic Cardiomyopathy: The Synergistic Potential of Sea Buckthorn and Metformin Explored via Bioinformatics and Chemoinformatics. Biology (Basel). 2025 Mar 31;14(4):. PMID: 40282226", "BibTeX": "@article{40282226, title={Mitigating Diabetic Cardiomyopathy: The Synergistic Potential of Sea Buckthorn and Metformin Explored via Bioinformatics and Chemoinformatics.}, author={Safavi K and Abedpoor N and Hajibabaie F and Kaviani E}, journal={Biology (Basel)}, volume={14}, number={4}}"}}, {"_id": "37759984", "pmid": 37759984, "pmcid": "PMC10525300", "title": "AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation", "journal": "Antioxidants (Basel)", "authors": ["Kang L", "Yi J", "Lau CW", "He L", "Chen Q", "Xu S", "Li J", "Xia Y", "Zhang Y", "Huang Y", "Wang L"], "date": "2023-08-28T00:00:00Z", "doi": "10.3390/antiox12091681", "meta_date_publication": "2023 Aug 28", "meta_volume": "12", "meta_issue": "9", "meta_pages": "", "score": 50243.08, "text_hl": "However, the role of @GENE_YAP1 @GENE_22601 @@@YAP@@@ in the vasoprotective effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@diabetic endothelial cell dysfunction@@@ is still unknown. ", "citations": {"NLM": "Kang L, Yi J, Lau CW, He L, Chen Q, Xu S, Li J, Xia Y, Zhang Y, Huang Y, Wang L. AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation Antioxidants (Basel). 2023 Aug 28;12(9):. PMID: 37759984", "BibTeX": "@article{37759984, title={AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation}, author={Kang L and Yi J and Lau CW and He L and Chen Q and Xu S and Li J and Xia Y and Zhang Y and Huang Y and Wang L}, journal={Antioxidants (Basel)}, volume={12}, number={9}}"}}, {"_id": "27487294", "pmid": 27487294, "title": "Metformin and Angiogenesis in Cancer - Revisited.", "journal": "Oncology", "authors": ["Kannarkatt J", "Alkharabsheh O", "Tokala H", "Dimitrov NV"], "date": "2016-01-01T00:00:00Z", "doi": "10.1159/000448175", "meta_date_publication": "2016", "meta_volume": "91", "meta_issue": "4", "meta_pages": "179-184", "score": 50061.605, "text_hl": "Several clinical studies demonstrated that @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ @SPECIES_9606 @@@patients@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ were less likely to develop @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@vascular complications@@@, independent of glycemic control. ", "citations": {"NLM": "Kannarkatt J, Alkharabsheh O, Tokala H, Dimitrov NV. Metformin and Angiogenesis in Cancer - Revisited. Oncology. 2016;91(4):179-184. PMID: 27487294", "BibTeX": "@article{27487294, title={Metformin and Angiogenesis in Cancer - Revisited.}, author={Kannarkatt J and Alkharabsheh O and Tokala H and Dimitrov NV}, journal={Oncology}, volume={91}, number={4}, pages={179-184}}"}}, {"_id": "21437084", "pmid": 21437084, "pmcid": "PMC3047998", "title": "Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update", "journal": "Diabetes Metab Syndr Obes", "authors": ["Moses RG"], "date": "2010-05-10T00:00:00Z", "doi": "10.2147/dmsott.s6621", "meta_date_publication": "2010 May 10", "meta_volume": "3", "meta_issue": "", "meta_pages": "145-54", "score": 50061.17, "text_hl": "Lifestyle advice plus @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is commonly recommended initially to manage @DISEASE_Hyperglycemia @DISEASE_MESH:D006943 @@@hyperglycemia@@@ and to minimize the risk of @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@vascular complications@@@. ", "citations": {"NLM": "Moses RG. Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update Diabetes Metab Syndr Obes. 2010 May 10;3():145-54. PMID: 21437084", "BibTeX": "@article{21437084, title={Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update}, author={Moses RG}, journal={Diabetes Metab Syndr Obes}, volume={3}, pages={145-54}}"}}, {"_id": "18991752", "pmid": 18991752, "title": "Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.", "journal": "Mini Rev Med Chem", "authors": ["Correia S", "Carvalho C", "Santos MS", "Seiça R", "Oliveira CR", "Moreira PI"], "date": "2008-11-01T00:00:00Z", "doi": "10.2174/138955708786369546", "meta_date_publication": "2008 Nov", "meta_volume": "8", "meta_issue": "13", "meta_pages": "1343-54", "score": 50061.055, "text_hl": "This review is mainly devoted to describe the mechanisms of action underlying the antidiabetic effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. Furthermore, we will present evidence for the protective effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ against @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@-associated complications mainly @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@cerebral and vascular complications@@@. ", "citations": {"NLM": "Correia S, Carvalho C, Santos MS, Seiça R, Oliveira CR, Moreira PI. Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview. Mini Rev Med Chem. 2008 Nov;8(13):1343-54. PMID: 18991752", "BibTeX": "@article{18991752, title={Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.}, author={Correia S and Carvalho C and Santos MS and Seiça R and Oliveira CR and Moreira PI}, journal={Mini Rev Med Chem}, volume={8}, number={13}, pages={1343-54}}"}}, {"_id": "24018893", "pmid": 24018893, "title": "Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.", "journal": "Endocr J", "authors": ["Sato Y", "Ouchi K", "Funase Y", "Yamauchi K", "Aizawa T"], "date": "2013-01-01T00:00:00Z", "doi": "10.1507/endocrj.ej13-0332", "meta_date_publication": "2013", "meta_volume": "60", "meta_issue": "12", "meta_pages": "1275-80", "score": 50060.73, "text_hl": "Secondly, the relationship between @CHEMICAL_zwittergent_3_12 @CHEMICAL_MESH:C034730 @@@B12@@@, @CHEMICAL_Homocysteine @CHEMICAL_MESH:D006710 @@@homocysteine@@@ and @<m>DISEASE_Diabetic_Angiopathies</m> @DISEASE_MESH:D003925 @@@vascular complications@@@ was analyzed in 46 @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated and 38 age- and sex-matched non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-treated @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Sato Y, Ouchi K, Funase Y, Yamauchi K, Aizawa T. Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes. Endocr J. 2013;60(12):1275-80. PMID: 24018893", "BibTeX": "@article{24018893, title={Relationship between metformin use, vitamin B12 deficiency, hyperhomocysteinemia and vascular complications in patients with type 2 diabetes.}, author={Sato Y and Ouchi K and Funase Y and Yamauchi K and Aizawa T}, journal={Endocr J}, volume={60}, number={12}, pages={1275-80}}"}}]}